Enko
PrivateLast Round
Series C
Jan 31, 2023
Est. Valuation
$320M
Total Funding Raised
$247M
Company Overview
Enko operates in Healthcare & Life Sciences and is based in Mystic, Connecticut. Its latest recorded funding round was a Series C round in January 2023.
Enko is an agricultural technology company that develops safe and sustainable small molecule solutions to help farmers protect their crops from pests and diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enko Comparables
Compare Enko with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Moa Technology | 87% | |
| Evogene | 77% | |
| Agrematch | 76% |
For institutional investors. Book with your work email.
Enko Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 31, 2023 | ||||
| Series C | Jul 27, 2022 | ||||
| Series B | Jun 26, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enko Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bits x Bites | Series B |
| Eight Roads Ventures | Series C |
| Germin8 Ventures | Series B, Series C |
| Anterra Capital | Series B, Series C, Series A, Seed |
| Endeavor8 | Series C |
| Bill & Melinda Gates Foundation | Series C, Series B |
| The Bill & Melinda Gates Foundation Trust | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 208% MoM, reaching 4.4K.
- Jan 1, 2026
Partnerships with Syngenta and Bayer disclosed in job posting.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- adopts_technologyOct 7, 2026
Enko Chem, Inc. uses AI platform ENDOMPASS to uncover new crop protection targets on Oct 7th '26.
- recognized_asSep 14, 2026
AgTech Breakthrough names Enko Chem, Inc.'s ENKOMPASS the winner of the AI-based AgTech Platform of the Year award in its 7th annual AgTech Breakthrough Awards program on Sep 14th '26 in California.
- receives_awardSep 14, 2026
AgTech Breakthrough selects Enko Chem, Inc. as the winner of the "AI-based AgTech Platform of the Year" award in the 7th annual AgTech Breakthrough Awards program in California on Sep 14th '26.
- attends_eventSep 14, 2026
Enko Chem, Inc. is selected as the winner of the AI-based AgTech Platform of the Year award at the 7th annual AgTech Breakthrough Awards program in California on Sept. 14th '26.
For institutional investors. Book with your work email.
Enko Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enko's valuation, stock price, and market status.
Is Enko a public or private company?
Enko is a private company.
What is the current stock price of Enko?
Enko is a private company, so its shares have no public market price. Caplight tracks Enko's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enko worth (valuation)?
Enko's valuation is estimated at $320.0M based on funding round data.
Can I buy Enko stock?
Enko shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enko's last funding round?
Enko's most recent funding round was Series C on January 31, 2023.
Who are the main investors in Enko?
Key investors in Enko include Eight Roads Ventures, Anterra Capital, Bill & Melinda Gates Foundation, The Bill & Melinda Gates Foundation Trust.
Will Enko IPO soon?
No public IPO plans have been announced for Enko.
How can I track Enko secondary market activity?
Caplight tracks bids, offers, and trades in Enko's shares on secondary markets.